blood-transfusion

Documents about blood-transfusion

• A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion#909569ClinicalTrials.gov
• A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.#915063ClinicalTrials.gov
• Estimation of the Safety and Efficiency Transfusion of HLA Matched CBU in Patients With CP#979669ClinicalTrials.gov
• Risk factors for blood transfusion during cesarean section in women with major placenta previa / Evgeni Baev ; Gutachter: Andreas Müller ; Betreuer: Andreas Müller ; Herausgeber: Nicht zutreffend#983080Deutsche Nationalbibliothek
• Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer#855280ClinicalTrials.gov
• Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)#913264ClinicalTrials.gov
• Predicting elevated transcranial doppler velocity among patients with sickle cell anemia in Uganda: A cross-sectional study#305608PLOS
• Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer#905591ClinicalTrials.gov
• A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study)#1010270ClinicalTrials.gov
• A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy#979492ClinicalTrials.gov
• Detection of placenta accreta spectrum and prediction of adverse perinatal outcomes in pregnant women with placenta previa using ultrasonography and magnetic resonance imaging: A retrospective cohort study#240433PLOS
• Identifying risk individuals for heart failure diagnosis within two years in the adult population in southern Sweden using gender, age, multimorbidity level, and socioeconomic status#342874Springer Nature OA
• Training Needs Assessment for Transitioning from Cesium-137 to X-ray Blood Irradiators in African Countries#395301HAL (France)
• Decision Aid for Therapeutic Options In Sickle Cell Disease#902042ClinicalTrials.gov
• CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial#226247ClinicalTrials.gov
• Erythropoietin, transfusions, and outcomes of retinopathy of prematurity and brain injury in extremely preterm infants: A post hoc analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT)#313062PLOS
• A Comparative Study of Different Hypothermic Circulatory Arrest Strategies on Aortic Surgery.#826637ClinicalTrials.gov
• Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery#862336ClinicalTrials.gov
• Clinical Importance of Treating Iron Overload in Sickle Cell Disease#916085ClinicalTrials.gov
• Pelvic embolization in severely traumatized patients in hemorrhagic shock with pelvic fractures without contrast extravasation on the initial CT scan: A retrospective comparative study between three French centers#157621HAL (France)
• Association Between ‘Emergency Obstetric & Newborn Care Readiness’ and Delivery Service Utilization in Bangladesh: Evidence From National Health Facility Assessment Surveys#446965Scholar Commons
• A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes#968551ClinicalTrials.gov
• 21 CFR Part 630 — Requirements for Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use#506874Code of Federal Regulations (eCFR)
• A Study to Evaluate the Safety and Efficacy of COVID-19 Convalescent Plasma (CCP) Transfusion to Prevent COVID-19 in Adult Recipients Following Hematopoietic Stem Cell Transplantation#981892ClinicalTrials.gov
• In the Matter of E And In The Matter Of A Minor Aged 16 And In The Matter Of A Blood Transfusion To Which The Minor Objects And Her Parents Do Not Consent (Approved) [2026] IEHC 134 (13 February 2026)#184464BAILII Ireland
• An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Requiring Red Blood Cell Transfusion#829220ClinicalTrials.gov
• EPO-4-Rhesus Study#854174ClinicalTrials.gov
• VA CoronavirUs Research and Efficacy Studies-1#801455ClinicalTrials.gov
• Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden#838357ClinicalTrials.gov
• Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS#913392ClinicalTrials.gov